• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=9809028).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Cys (c.730G>T); ClinVar=VCV000376599; Zygosity=Unspecified (PubMed=9809028; PubMed=10841287).
  

PubMed=9809028; DOI=10.1016/S0165-4608(98)00076-4
Anna Gasperi-Campani, Laura Roncuzzi, Luca Ricotti, Laura Lenzi, Rita Gruppioni, Alberto Sensi, Nicoletta Zini, Wainer Zoli, Dino Amadori;
Molecular and biological features of two new human squamous and adenocarcinoma of the lung cell lines.
Cancer Genet. Cytogenet. 107:11-20(1998)

PubMed=10574245; DOI=10.1038/sj.bjc.6690737; PMCID=PMC2362882
Wainer Zoli, Luca Ricotti, Monica Dal Susino, Fabio Barzanti, Giovanni Luca Frassineti, Secondo Folli, Anna Tesei, Francesco Bacci, Dino Amadori;
Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer.
Br. J. Cancer 81:609-615(1999)

PubMed=10841287
Daniele Calistri, Fabio Barzanti, Monica Dal Susino, Roberta Fedriga, Luca Saragoni, Lisiane Bernardi, Luca Ricotti, Wainer Zoli;
Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologies.
J. Biol. Regul. Homeost. Agents 14:120-127(2000)

PubMed=26919099; DOI=10.18632/oncotarget.7575; PMCID=PMC4951299
Chiara Arienti, Michele Zanoni, Sara Pignatta, Alberto Del Rio, Silvia Carloni, Michela Tebaldi, Gianluca Tedaldi, Anna Tesei;
Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.
Oncotarget 7:18424-18439(2016)